Source: Sartorius Stedim Biotech

Sartorius Inks Automation Cooperation Agreement with Siemens

Sartorius Stedim Biotech and Siemens agree to a long-term cooperation agreement in the area of automation
Source: David Jones

Plastic: An Acquired Taste, Even If You’re an Aromatic Polyesterase

Protein engineering work improves a naturally occurring enzyme's ability to degrade polyethylene terephthalate (PET), one of the most abundantly produced synthetic polymers
GE Healthcare's "factory-in-a-box.

Factory in a Box Launched for Production of Viral Vector–Based Therapeutics

Factory in a box products include vaccines, oncolytic viruses, and gene and cell therapies.

Fujifilm Acquiring Irvine Scientific, IS Japan for $800M, with Cell Culture Media Growth in...

Both companies to be acquired serve biopharmas and academic institutions by offering culture media for biopharmaceutical production, in vitro fertilization, and cell therapy
Synthetic biomaterials can draw on the power of post-translational modification to accomplish temperature-triggered self-assembly

Self-Assembling Lipid–Polypeptide Biomaterials Follow Heat Cues

Synthetic biomaterials draw on the power of post-translational modification to accomplish temperature-triggered self-assembly, which may advance injectability in tissue engineering, as opposed to implantability
Transmembrane proteins with multiple membrane-spanning regions have been designed by computer and shown to be highly stable when embedded in the plasma membrane in bacteria and mammalian cells. In this image

Designer Multipass Transmembrane Proteins the Latest Cellwear

Transmembrane proteins with multiple membrane-spanning regions have been designed by computer and shown to be highly stable when embedded in the plasma membrane in bacteria and mammalian cells

Evolution of Engineered Organisms Constrains Bioproduction

Evolution causes the rise of unproductive microbial variants in large-scale bioproduction processes, necessitating strategies to pause productivity-degrading evolutionary mechanisms

Seattle Genetics, Pieris Launch Up-to-$1.2B Immuno-Oncology Collaboration

The companies would work to create antibody–anticalin fusion proteins for solid tumors and blood cancers
Clover Biopharmaceuticals has selected GE Healthcare's FlexFactory™ single-use biomanufacturing platform for its new facility in Changxing

Clover Biopharmaceuticals Selects GE Healthcare’s FlexFactory for New Facility

SCB-808, a prefilled syringe formulation Enbrelâ (etanercept) biosimilar candidate, will be the first therapeutic product to be produced at Clover’s facility using FlexFactory
Columbia biomedical engineers use soft fibers (red) to activate T cells (green)

Novel Biomaterials Boost T-Cell Production

New technique improves T-cell manufacture by focusing on the production materials.
-Advertisement-

Recently Featured

Stay Connected

558,376FansLike
790FollowersFollow
45,350FollowersFollow
Scroll Up